420 related articles for article (PubMed ID: 17260122)
1. Rapamycin as an inhibitor of osteogenic differentiation in bone marrow-derived mesenchymal stem cells.
Isomoto S; Hattori K; Ohgushi H; Nakajima H; Tanaka Y; Takakura Y
J Orthop Sci; 2007 Jan; 12(1):83-8. PubMed ID: 17260122
[TBL] [Abstract][Full Text] [Related]
2. [Osteoblastic differentiation and in vivo osteogenic activity of marrow-derived mesenchymal stem cells stimulated by Tacrolimus: experiment with rats].
Dong J; Dai WD; Fang TL; Lin H; Uemura T
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):190-4. PubMed ID: 17425851
[TBL] [Abstract][Full Text] [Related]
3. Osteogenic differentiation of rat mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells: melatonin as a differentiation factor.
Zaminy A; Ragerdi Kashani I; Barbarestani M; Hedayatpour A; Mahmoudi R; Farzaneh Nejad A
Iran Biomed J; 2008 Jul; 12(3):133-41. PubMed ID: 18762816
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene: its ossification-promoting effect on female mesenchymal stem cells.
Matsumori H; Hattori K; Ohgushi H; Dohi Y; Ueda Y; Shigematsu H; Satoh N; Yajima H; Takakura Y
J Orthop Sci; 2009 Sep; 14(5):640-5. PubMed ID: 19802678
[TBL] [Abstract][Full Text] [Related]
5. The effect of purmorphamine and sirolimus on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells.
Faghihi F; Baghaban Eslaminejad M; Nekookar A; Najar M; Salekdeh GH
Biomed Pharmacother; 2013 Feb; 67(1):31-8. PubMed ID: 23228449
[TBL] [Abstract][Full Text] [Related]
6. In vivo osteogenic capability of cultured allogeneic bone in porous hydroxyapatite: immunosuppressive and osteogenic potential of FK506 in vivo.
Yoshikawa T; Nakajima H; Yamada E; Akahane M; Dohi Y; Ohgushi H; Tamai S; Ichijima K
J Bone Miner Res; 2000 Jun; 15(6):1147-57. PubMed ID: 10841184
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of osteogenic activity in mesenchymal stem cells by FK506.
Dai W; Dong J; Fang T; Uemura T
J Biomed Mater Res A; 2008 Jul; 86(1):235-43. PubMed ID: 18080300
[TBL] [Abstract][Full Text] [Related]
8. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.
Guang LG; Boskey AL; Zhu W
Int J Biochem Cell Biol; 2013 Aug; 45(8):1813-20. PubMed ID: 23742988
[TBL] [Abstract][Full Text] [Related]
9. FK506 enhanced osteoblastic differentiation in mesenchymal cells.
Tang L; Ebara S; Kawasaki S; Wakabayashi S; Nikaido T; Takaoka K
Cell Biol Int; 2002; 26(1):75-84. PubMed ID: 11779223
[TBL] [Abstract][Full Text] [Related]
10. Biomineral/Agarose Composite Gels Enhance Proliferation of Mesenchymal Stem Cells with Osteogenic Capability.
Suzawa Y; Kubo N; Iwai S; Yura Y; Ohgushi H; Akashi M
Int J Mol Sci; 2015 Jun; 16(6):14245-58. PubMed ID: 26110392
[TBL] [Abstract][Full Text] [Related]
11. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
[TBL] [Abstract][Full Text] [Related]
12. Osteogenic phenotype expression of allogeneic rat marrow cells in porous hydroxyapatite ceramics.
Akahane M; Ohgushi H; Yoshikawa T; Sempuku T; Tamai S; Tabata S; Dohi Y
J Bone Miner Res; 1999 Apr; 14(4):561-8. PubMed ID: 10234577
[TBL] [Abstract][Full Text] [Related]
13. Pulsed electromagnetic fields stimulate osteogenic differentiation in human bone marrow and adipose tissue derived mesenchymal stem cells.
Ongaro A; Pellati A; Bagheri L; Fortini C; Setti S; De Mattei M
Bioelectromagnetics; 2014 Sep; 35(6):426-36. PubMed ID: 25099126
[TBL] [Abstract][Full Text] [Related]
14. [EXPERIMENTAL STUDY ON OSTEOGENESIS OF SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS IN VITRO AND IN VIVO].
Zheng W; Yang M; Wu C; Su X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Jan; 30(1):102-9. PubMed ID: 27062856
[TBL] [Abstract][Full Text] [Related]
15. Effects of simvastatin on the osteogenic differentiation and immunomodulation of bone marrow mesenchymal stem cells.
Niu J; Ding G; Zhang L
Mol Med Rep; 2015 Dec; 12(6):8237-40. PubMed ID: 26499955
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal cells can rescue osteogenic capacity of devitalized autologous bone.
Tohma Y; Ohgushi H; Morishita T; Dohi Y; Tadokoro M; Tanaka Y; Takakura Y
J Tissue Eng Regen Med; 2008 Jan; 2(1):61-8. PubMed ID: 18361480
[TBL] [Abstract][Full Text] [Related]
17. Myricetin enhances osteogenic differentiation through the activation of canonical Wnt/β-catenin signaling in human bone marrow stromal cells.
Ying X; Chen X; Feng Y; Xu HZ; Chen H; Yu K; Cheng S; Peng L
Eur J Pharmacol; 2014 Sep; 738():22-30. PubMed ID: 24876056
[TBL] [Abstract][Full Text] [Related]
18. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells or bone marrow-derived mesenchymal stem cells.
Both SK; van Apeldoorn AA; Jukes JM; Englund MC; Hyllner J; van Blitterswijk CA; de Boer J
J Tissue Eng Regen Med; 2011 Mar; 5(3):180-90. PubMed ID: 20718035
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells.
Gong Z; Wezeman FH
Alcohol Clin Exp Res; 2004 Mar; 28(3):468-79. PubMed ID: 15084905
[TBL] [Abstract][Full Text] [Related]
20. Optimizing In Vitro Osteogenesis in Canine Autologous and Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells with Dexamethasone and BMP-2.
Gasson SB; Dobson LK; Chow L; Dow S; Gregory CA; Saunders WB
Stem Cells Dev; 2021 Feb; 30(4):214-226. PubMed ID: 33356875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
